- Orchard Therapeutics is the category leader for engineering and developing hematopoietic stem cell medicines.
- The company's platform has been validated with 2 approvals in Europe and a diverse pipeline of drug candidates.
- Hematopoietic stem cells have curative potential for many diseases with a unique opportunity in central nervous system diseases.
- The company's stock is one to monitor as they make a pivot from diseases with smaller patient populations to larger ones.
For further details see:
Orchard Therapeutics: Curative Medicines For Immune-Related Diseases